• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Recombinant tissue-type plasminogen activator (rt-PA) effectively restores neurological function and improves prognosis in acute ischemic stroke
CONCLUSION: Compared with conventional pharmacological regimens, additional rt-PA intravenous thrombolytic therapy improves the clinical outcome of patients with acute ischemic stroke, promotes neurological recovery, and enhances patient prognosis without increasing the risk of patient-related adverse events.PMID:37303683 | PMC:PMC10251022
Source: American Journal of Translational Research - June 12, 2023 Category: Research Authors: Shouyun Zhang Dezhen Wang Lin Li Source Type: research

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke.
CONCLUSIONS In our trial involving patients with acute cerebral infarction, BPS plus aspirin was not found to be superior to aspirin in reducing the recurrence of cerebral infarction or death. However, BPS plus aspirin treatment could improve renal function and neurological function without increasing the risk of bleeding. PMID: 28898204 [PubMed - in process]
Source: Medical Science Monitor - September 13, 2017 Category: Research Tags: Med Sci Monit Source Type: research

Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration
CONCLUSIONS: Aspirin combined with argatroban significantly improved neurological impairment of AIS patients with END, which is worthy of clinical application.PMID:37105928 | DOI:10.24976/Discov.Med.202335175.19
Source: Discovery Medicine - April 27, 2023 Category: Research Authors: Shu Xu Wenjun Zhang Yan Zhang Zhou Xu Ting Wu Source Type: research

Pages: 1  2  3  4